Trade GNPX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Genprex, Inc. (GNPX) is trading at US$3.49, up 1.01% today as of Sep 21, 15:53 EDT. The company has a market capitalisation of US$3.24M. Over the past 52 weeks, GNPX has traded between US$3.26 and US$1,210.00. On Syfe you can trade GNPX with $0 commission and add it to your watchlist.
| Previous close | US$3.45 |
|---|---|
| Market cap | US$3.24M |
| 52-week range | US$3.26 – US$1,210.00 |
| Volume | 57.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.
Year: 2018
Genprex, Inc. (GNPX) stock is trading at US$3.49, +1.01% from the previous close of US$3.45.
The market cap for Genprex, Inc. (GNPX) stock is approximately US$3.24M.
The 52-week high for Genprex, Inc. (GNPX) stock is US$1,210.00.
The 52-week low for Genprex, Inc. (GNPX) stock is US$3.26.
Genprex, Inc. (GNPX) does not currently pay a dividend.
Stay on top of GNPX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
